版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡介
www.MedChemEHighQualityAffordablePricesQuickDeliveryProfessionalTech-supportTopSellingProductsCitedin30,000+Publications.InVitro/VivoMechanismsofAction.24/7CustomerService!Cell.2023Feb2;186(3):591-606.e23.Nature.2023Jan;613(7942):187-194.DoxycyclinepurchasedfromMCE.S63845,Venetoclax,A-1331852purchasedfromMCE.Cell.2023Jan5;S0092-8674(22)01538-0.Science.2022Nov18;378(6621):eabq7361.HomoharringtoninepurchasedfromMCE.Nocodazole,Milrinone,Hoechst33342purchasedfromMCE.Cell.2023Jan19;186(2):413-427.e17.Science.2022Oct14;378(6616):eabq0132.DAMGOTFA,Deltorphin2TFApurchasedfromMCEIL-18BP,MousepurchasedfromMCE.
Nature.2023Feb;614(7947):326-333.FinerenonepurchasedfromMCE.Nature.2022Dec;612(7941):725-731.ChloroquinepurchasedfromMCE.Science.2022Dec2;378(6623):eabo5503.DAPTpurchasedfromMCE.MCEMasterofBioactiveMoleculesCancerResearchCat.No:HY-13259Cat.No:HY-10219Cat.No:HY-100579MG-132RapamycinFerrostatin-1ProteasomeInhibitormTORInhibitorFerroptosisInhibitor556Citations529Citations284CitationsCat.No:HY-15763Cat.No:HY-19312Cat.No:HY-17394Erastin3-Methyladenine(3-MA)CisplatinFerroptosisInducerPI3KInhibitorDNAAlkylator158Citations475Citations263CitationsCat.No:HY-100558Cat.No:HY-100218ACat.No:HY-16658BBafilomycinA1RSL3Z-VAD-FMKV-ATPaseInhibitorFerroptosisActivatorPanCaspaseInhibitor239Citations95Citations190CitationsCat.No:HY-B0215Cat.No:HY-10162Cat.No:HY-10108AcetylcysteineOlaparibLY294002ROSInhibitorPARPInhibitorPI3KInhibitor210Citations139Citations562CitationsCat.No:HY-10583Cat.No:HY-13757ACat.No:HY-B0015Y-27632dihydrochlorideTamoxifenPaclitaxelROCKInhibitorEstrogenReceptorModulatorAntineoplasticAgent147CitationsCitedbyCell.129CitationsCat.No:HY-13418ACat.No:HY-100523Cat.No:HY-114277DorsomorphinML385SotorasibAMPKInhibitorNRF2InhibitorKRASG12CCovalentInhibitor279Citations182CitationsCitedbyNatGenet.Anti-InfectionResearchCat.No:HY-B1743ACat.No:HY-13433Cat.No:HY-16592PuromycindihydrochlorideThapsigarginBrefeldinAAntibioticCa2+-ATPaseInhibitorCRISPR/Cas9Activator81Citations30CitationsCitedbyNatMicrobiol.Cat.No:HY-100381Cat.No:HY-13434Cat.No:HY-10221NigericinsodiumsaltIonomycinVorinostatNLRP3ActivatorCalciumIonophore/AntibioticHDACInhibitor31CitationsCitedbyCellMolImmunol.72CitationsInflammation/ImmunologyResearchCat.No:HY-17589ACat.No:HY-14648ChloroquineDexamethasoneAutophagy/TLRsInhibitorGRAgonist224Citations86CitationsCat.No:HY-12815ACat.No:HY-11109MCC950sodiumResatorvid(TAK-242)NLRP3InhibitorTLR4Inhibitor96Citations291CitationsCat.No:HY-B0579Cat.No:HY-19363CyclosporinAGW4869CalcineurinInhibitorN-SMaseInhibitor71Citations84Citations
Cat.No:HY-15371ForskolinAdenylateCyclaseActivator59CitationsCat.No:HY-12318IBMXPhosphodiesteraseInhibitorCitedbyMolCell.Cat.No:HY-18739PMASphK/PKCActivator140CitationsNeurologicalDiseaseResearchCat.No:HY-13027Cat.No:HY-114153Cat.No:HY-18749DAPTPLX5622SC79γ-secretaseInhibitorCSF1RInhibitorAktActivator72CitationsCitedbyNature.104CitationsMetabolicDiseaseResearchCat.No:HY-17386Cat.No:HY-B0240Cat.No:HY-B0627RosiglitazoneDisulfiramMetforminPPARγAgonistALDH1InhibitorAMPKActivator53CitationsCitedbyNatCancer.34CitationsCardiovascularDiseaseResearchCat.No:HY-B0468Cat.No:HY-17567ACat.No:HY-18723IsoprenalinehydrochlorideHeparinsodiumsaltYoda1β-adrenergicReceptorAgonistAnticoagulantPiezo1AgonistCitedbyScience.CitedbyCellRes.CitedbyCancerCommun.EndocrinologyResearchCat.No:HY-101952Cat.No:HY-N0583Cat.No:HY-B0141ProstaglandinE2HydrocortisoneEstradiolHormone-likeSubstanceSteroidHormoneFemaleSexHormoneCitedbyCellStemCell.CitedbyNature.35Citationswww.MedChemEInhibitors?ScreeningLibraries?ProteinsRecombinantProteinsCat.No:HY-P7109Cat.No:HY-P7025Cat.No:HY-P7118EGF,HumanIFN-gamma,HumanTGFbeta1/TGFB1,HumanCat.No:HY-P7058Cat.No:HY-P7004Cat.No:HY-P7085TNF-alpha/TNFSF2,HumanFGFbasic/bFGF,HumanM-CSF,MouseFluorescentDyesCat.No:HY-D0969Cat.No:HY-D0940Cat.No:HY-W090090DiOH2DCFDA(Green)BODIPY493/503Cat.No:HY-15534Cat.No:HY-D0041Cat.No:HY-D1301JC-1Calcein-AMBODIPY581/591C11BiochemicalAssayReagentsCat.No:HY-17031Cat.No:HY-Y1891Cat.No:HY-Y0320SBE-β-CDTween80DimethylsulfoxideIsotope-LabeledCompoundsCat.No:HY-15162ACat.No:HY-13631ASCat.No:HY-19939SMMAE-d8Exatecan-d5mesylateVX-984PeptidesCat.No:HY-P1731Cat.No:HY-P0035Cat.No:HY-13443TirzepatideInsulin(human)Exendin-4InhibitoryAntibodiesCat.No:HY-P9906Cat.No:HY-P9908Cat.No:HY-P9912BevacizumabAdalimumabPertuzumabCat.No:HY-P9926Cat.No:HY-P9901Cat.No:HY-P9902Dupilumab Ipilimumab Pembrolizumabwww.MedChemELifeScienceProductsKitsMagneticBeadsCat.No:HY-K0202Cat.No:HY-K0207Cat.No:HY-K0208andAgaroseProteinA/GMagneticBeadsAnti-FlagMagneticBeadsStreptavidinMagneticBeadsInhibitor Cat.No:HY-K0030 Cat.No:HY-K0021 Cat.No:HY-K0010Cocktails DeacetylaseInhibitorCocktailPhosphataseInhibitorCocktailI ProteaseInhibitorCocktailCat.No:HY-K0301Cat.No:HY-K2014Cat.No:HY-K1090CellCountingKit-8PEITransfectionReagentCytotoxicityLDHAssayKitCellCultureandAnalysisCat.No:HY-K1014Cat.No:HY-T1000Cat.No:HY-K0302PolyFastTransfectionReagentFetalBovineSerumCTGCellViabilityDetection(Superfine),UruguayOtherCat.No:HY-K1005Cat.No:HY-K1033Cat.No:HY-K1001KitsUltraHighSensitivityECLKitRNaseInhibitorRIPALysisBuffer(Strong)CustomerValidation案例一細(xì)胞:過表達(dá)WTNFS1 mutant細(xì)胞應(yīng)用:IP實(shí)驗(yàn)(HY-K0202ProteinA/GMagneticBeads)分析在沒有奧沙利鉑處理的情況下,過表達(dá)WTNFS1或NFS1突變體S293A或NFS1突變體S293D的細(xì)胞中2937NFS1的絲氨酸磷酸化水平。Citedin:SignalTransductTargetTher.2022Feb28;7(1):54.案例二
293TF-NFS1WTS293AS293DP-SerIP:FlagFlagFlagInputWT
DAPINileRedMerge細(xì)胞:G4細(xì)胞染色檢測突變型和野生型細(xì)胞中的TAG應(yīng)用:用NileRed(HY-D0718)含量,發(fā)現(xiàn)在G4-mutantcells中TAG含量顯著降低Citedin:NucleicAcidsRes.2022Jun24;50(12):6953-67.G4-mutFormoredetails,pleasevisitouronlinewebsitewww.MedChemE案例三細(xì)胞:HaCaT細(xì)胞應(yīng)用:tFNAs逆轉(zhuǎn)TGF-β(HY-P7118,5ng/mL)誘導(dǎo)的HaCaT細(xì)胞纖維化。免疫熒光(IF)結(jié)果圖以及統(tǒng)計(jì)分析HaCaT細(xì)胞中α-SMA的表達(dá)。Citedin:ACSApplMaterInterfaces.2022Apr6;14(13):15069-15079.TGF-βTGF-β+TGF-β+Ctrl125nMT250nMTα-SMAFITCDAPIHighLow
α-SMA***SMA6.01.5****ofα-expression1.0intensityof4.00.52.0Relative0.0ctrlTGF-βTGF-β+TGF-β+Relative0.0125nMT250nMT
*****ctrl TGF-βTGF-β+ TGF-β+125nMT250n
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 感動中國先進(jìn)人物事跡(11篇)
- 開展節(jié)能宣傳活動總結(jié)
- 愚人節(jié)活動策劃(集錦15篇)
- 高中生物教師提升職稱答辯題目精 選8題
- 關(guān)于彩虹小知識
- 2016山西道法試卷+答案+解析
- 超聲引導(dǎo)下坐骨神經(jīng)阻滯聯(lián)合股神經(jīng)阻滯在糖尿病患者膝關(guān)節(jié)以下截肢手術(shù)中的應(yīng)用效果分析
- 產(chǎn)業(yè)研究報(bào)告-中國糧油行業(yè)發(fā)展現(xiàn)狀、市場規(guī)模、投資前景分析(智研咨詢)
- 二零二五年度航空航天投資理財(cái)合同模板3篇
- 銷售渠道的選擇與管理培訓(xùn)
- 課題申報(bào)書:GenAI賦能新質(zhì)人才培養(yǎng)的生成式學(xué)習(xí)設(shè)計(jì)研究
- 潤滑油知識-液壓油
- 2024年江蘇省中醫(yī)院高層次衛(wèi)技人才招聘筆試歷年參考題庫頻考點(diǎn)附帶答案
- 駱駝祥子-(一)-劇本
- 全國醫(yī)院數(shù)量統(tǒng)計(jì)
- 《中國香文化》課件
- 2024年醫(yī)美行業(yè)社媒平臺人群趨勢洞察報(bào)告-醫(yī)美行業(yè)觀察星秀傳媒
- 第六次全國幽門螺桿菌感染處理共識報(bào)告-
- 天津市2023-2024學(xué)年七年級上學(xué)期期末考試數(shù)學(xué)試題(含答案)
- 經(jīng)濟(jì)學(xué)的思維方式(第13版)
- 盤錦市重點(diǎn)中學(xué)2024年中考英語全真模擬試卷含答案
評論
0/150
提交評論